Compare AstraZeneca plc (AZN) vs Becton Dickinson and Co (BDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AstraZeneca plc vs Becton Dickinson and Co — how do they compare? AstraZeneca plc trades at $157.99 (market cap $248.14B), while Becton Dickinson and Co trades at $180.75 (market cap $49.41B). The key difference: AstraZeneca plc is far larger — about 5× Becton Dickinson and Co's market cap, and Becton Dickinson and Co pays the higher dividend (2.32%). Which is the better fit depends on your goals.
| AZN | BDX | |
|---|---|---|
Market Cap | $248.14B | $49.41B |
Sector | Health | Health |
52-Week High | $209.48 | $185.39 |
52-Week Low | $147.06 | $138.62 |
Enterprise Value | $275.41B | $65.51B |
Dividend Yield | 2.01% | 2.32% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AstraZeneca plc
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →About Becton Dickinson and Co
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →
